Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,447,931
  • Shares Outstanding, K 45,040
  • Annual Sales, $ 593,750 K
  • Annual Income, $ 112,170 K
  • 36-Month Beta 0.35
  • Price/Sales 23.71
  • Price/Cash Flow 112.36
  • Price/Book 17.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.94
  • Number of Estimates 7
  • High Estimate 1.01
  • Low Estimate 0.88
  • Prior Year 0.70
  • Growth Rate Est. (year over year) +34.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
301.12 +6.50%
on 11/15/18
427.70 -25.02%
on 11/07/18
-66.18 (-17.11%)
since 10/16/18
3-Month
301.12 +6.50%
on 11/15/18
459.75 -30.24%
on 10/01/18
-48.27 (-13.08%)
since 08/16/18
52-Week
186.72 +71.75%
on 12/06/17
459.75 -30.24%
on 10/01/18
+125.79 (+64.54%)
since 11/16/17

Most Recent Stories

More News
Here's Why You Should Buy Integer Holdings (ITGR) Stock Now

Integer Holdings' (ITGR) bullish guidance paints a bright picture. Moreover, its solid focus on portfolio management is likely to provide the company with a competitive edge in the MedTech space.

ITGR : 85.75 (+1.91%)
ABMD : 319.47 (-0.41%)
MASI : 109.55 (+0.70%)
DXCM : 138.15 (+1.77%)
Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year?

Is (ABMD) Outperforming Other Medical Stocks This Year?

ABMD : 319.47 (-0.41%)
Company News For Nov 13, 2018

Companies In The News Are: ABMD,ISCA,SAP,PM

SAP : 104.54 (-0.89%)
ABMD : 319.47 (-0.41%)
ISCA : 43.54 (+1.26%)
PM : 86.33 (+0.58%)
Today's Research Reports on Stocks to Watch: ReShape Lifesciences and ABIOMED

NEW YORK, NY / ACCESSWIRE / November 13, 2018 / It was a day of red for ReShape Lifesciences and ABIOMED on Monday. Both stocks had double digit losses despite encouraging developments reported.

ABMD : 319.47 (-0.41%)
RSLS : 1.24 (-13.29%)
FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible

Abiomed (NASDAQ: ABMD) announces the results of the FDA STEMI Door-to-Unloading safety and feasibility randomized controlled trial, which show unloading the left ventricle with Impella...

ABMD : 319.47 (-0.41%)
ABIOMED (ABMD) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in ABIOMED, Inc. (ABMD).

ABMD : 319.47 (-0.41%)
SmarTrend Watching for Potential Pullback in Shares of Abiomed Inc After 6.63% Gain

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $402.00 to a high of $427.70. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of...

ABMD : 319.47 (-0.41%)
Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Abiomed (ABMD) closed at $389.85, marking a -0.78% move from the previous day.

ABMD : 319.47 (-0.41%)
Hill-Rom Holding has the Best Relative Performance in the Health Care Equipment Industry (HRC , ABMD , CSII , BDX , TFX )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

ABMD : 319.47 (-0.41%)
HRC : 94.37 (+1.75%)
CSII : 30.49 (+1.03%)
Abiomed (ABMD) Q2 Earnings Beat, Impella Maintains Momentum

Abiomed's (ABMD) flagship Impella sees a solid Q2; fiscal 2019 outlook raised.

MMSI : 61.28 (+3.69%)
SYK : 172.11 (+2.01%)
ABMD : 319.47 (-0.41%)
ISRG : 518.46 (+0.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 338.55
1st Resistance Point 329.66
Last Price 319.47
1st Support Level 306.51
2nd Support Level 292.24

See More

52-Week High 459.75
Fibonacci 61.8% 355.45
Fibonacci 50% 323.23
Last Price 319.47
Fibonacci 38.2% 291.02
52-Week Low 186.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar